Mar 20 |
Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket
|
Mar 20 |
Taysha Gene Therapies jumps after early data for Rett syndrome candidate
|
Mar 20 |
Q4 2023 Taysha Gene Therapies Inc Earnings Call
|
Mar 20 |
Taysha Gene Therapies, Inc. (TSHA) Q4 2023 Earnings Call Transcript
|
Mar 19 |
Taysha Gene Therapies, Inc. 2023 Q4 - Results - Earnings Call Presentation
|
Mar 19 |
Taysha Gene Therapies GAAP EPS of -$0.96 beats by $0.47, revenue of $15.5M beats by $1.02M
|
Mar 19 |
Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updates
|
Mar 18 |
Taysha Gene Therapies Q4 2023 Earnings Preview
|
Mar 14 |
Taysha Gene Therapies to Release Full-Year 2023 Financial Results, Provide Corporate and Clinical Updates and Host Conference Call on March 19
|
Feb 29 |
Taysha Gene Therapies Announces Updates to TSHA-102 Clinical Program in Rett Syndrome
|